FABP4 and rheumatoid arthritis: To further identify the therapeutic effects of FABP4 inhibitors on the development of the RA phenotype in vivo, we examined the histopathological characteristics of TSC1KO mice that were treated with BMS309403 or anagliptin after AIA surgery.